Activation assay for the diagnosis of a heparin-induced thrombocytopenia
US11262357B2 · kind B2 · utility
0Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 2018 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | Feb 14, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/226
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a functional, easily automatable assay for establishing a heparin-induced thrombocytopenia (HIT). What is measured is the secretion of PF4 (platelet factor 4) from activated thrombocytes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.